Source link : https://www.newshealth.biz/health-news/fda-approves-dupilumab-as-add-on-for-copd/
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary disease (COPD) is inadequately controlled with inhaler therapy, according to a press release from manufacturer Regeneron. Dupilumab, a fully human monoclonal antibody sold under the brand name, Dupixent, inhibits the signaling of the interleukin 4 […]
Author : News Health
Publish date : 2024-10-01 07:47:04
Copyright for syndicated content belongs to the linked Source.
